retatrutide vs mounjaro Mounjaro: The Future of Weight Management? – Trim Retatrutide vs Wegovy vs Mounjaro

The compound has generated significant interest among researchers investigating receptor signaling, metabolic pathway activity, and multi-receptor agonist models

Frontiers in Endocrinology, 16 , 1605746

Obesity prevalence has doubled since 1990, with one in eight individuals being obese worldwide

Individual susceptibility varies considerably

Notably, muscle cramps are not prominently featured among the listed adverse reactions in FDA labeling, leading many patients and clinicians to question whether there is a genuine association between GLP-1 therapy and musculoskeletal symptoms

However, Lilly stated that no major cardiac or liver safety issues were observed during the trial